ENTITY

Latigo Biotherapeutics (LTGO US)

7
Analysis
Health Care • United States
Latigo Biotherapeutics, Inc. is a biopharmaceutical company. The Company develops non-opioid pain medicines designed to stop the transmission of pain without the risk of addiction. Latigo Biotherapeutics operates in the United States.
more
Exchange Announcement • 04 Sep 2026 04:32

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 11 Aug 2026 04:52

S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Exchange Announcement • 11 Aug 2026 04:02

Current Report (Form 8-K | Period ending 2026-08-10)

Exchange Announcement • 07 Aug 2026 05:08

S-1MEF | A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form S 1

No more filings
x